These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2704926)

  • 1. Economic benefits of an effective infection control program: case study and proposal.
    Miller PJ; Farr BM; Gwaltney JM
    Rev Infect Dis; 1989; 11(2):284-8. PubMed ID: 2704926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hospital costs of nosocomial infections: a prospective three-month study in a community hospital.
    Scheckler WE
    Infect Control; 1980; 1(3):150-2. PubMed ID: 6905810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Can nosocomial infections be prevented?].
    Chidiac C; Leroy O; Mouton Y
    Rev Prat; 1989 May; 39(16):1409-12. PubMed ID: 2740793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High cost nosocomial infections.
    Pinner RW; Haley RW; Blumenstein BA; Schaberg DR; Von Allmen SD; McGowan JE
    Infect Control; 1982; 3(2):143-9. PubMed ID: 6918370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals.
    Haley RW; Culver DH; White JW; Morgan WM; Emori TG; Munn VP; Hooton TM
    Am J Epidemiol; 1985 Feb; 121(2):182-205. PubMed ID: 4014115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costs of treating simple nosocomial urinary tract infection.
    Rutledge KA; McDonald HP
    Urology; 1985 Jul; 26(1 Suppl):24-6. PubMed ID: 3925611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs.
    Umscheid CA; Mitchell MD; Doshi JA; Agarwal R; Williams K; Brennan PJ
    Infect Control Hosp Epidemiol; 2011 Feb; 32(2):101-14. PubMed ID: 21460463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost of hospital-associated infections in Massachusetts.
    Stone PW; Kunches L; Hirschhorn L
    Am J Infect Control; 2009 Apr; 37(3):210-4. PubMed ID: 19111366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Daily antibiotic cost of nosocomial infections in a Turkish university hospital.
    Inan D; Saba R; Gunseren F; Ongut G; Turhan O; Yalcin AN; Mamikoglu L
    BMC Infect Dis; 2005 Jan; 5():5. PubMed ID: 15679899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nosocomial urinary tract infections.
    Cox CE
    Urology; 1988 Sep; 32(3):210-5. PubMed ID: 3046098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic analysis of nosocomial infections in a Turkish university hospital.
    Yalçin AN; Hayran M; Unal S
    J Chemother; 1997 Dec; 9(6):411-4. PubMed ID: 9491840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized crossover study of silver-coated urinary catheters in hospitalized patients.
    Karchmer TB; Giannetta ET; Muto CA; Strain BA; Farr BM
    Arch Intern Med; 2000 Nov; 160(21):3294-8. PubMed ID: 11088092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nosocomial infections: etiologic changes, therapeutic challenges.
    Stamm WE
    Hosp Pract (Off Ed); 1981 Aug; 16(8):75-88. PubMed ID: 6790414
    [No Abstract]   [Full Text] [Related]  

  • 14. Update from the SENIC project. Hospital infection control: recent progress and opportunities under prospective payment.
    Haley RW; Morgan WM; Culver DH; White JW; Emori TG; Mosser J; Hughes JM
    Am J Infect Control; 1985 Jun; 13(3):97-108. PubMed ID: 3849273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing preventable harm: comment on "Clinical and economic outcomes attributable to health care-associated sepsis and pneumonia".
    Murphy DJ; Pronovost PJ
    Arch Intern Med; 2010 Feb; 170(4):353-5. PubMed ID: 20177038
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hospital infection, risk and consequences].
    Geroulanos S; Attinger B
    Schweiz Rundsch Med Prax; 1991 Mar; 80(12):291-6. PubMed ID: 2028136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A method to determine hospital costs associated with nosocomial infections].
    Gianino MM; Vallino A; Anselmo E; Minniti D; Abbona F; Mineccia C; Silvaplana P; Zotti CM
    Ann Ig; 2007; 19(4):381-92. PubMed ID: 17937330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surveillance by objective: a new priority-directed approach to the control of nosocomial infections. The National Foundation for Infectious Diseases lecture.
    Haley RW
    Am J Infect Control; 1985 Apr; 13(2):78-89. PubMed ID: 3846430
    [No Abstract]   [Full Text] [Related]  

  • 19. An economic model to assess the cost and benefits of the routine use of silver alloy coated urinary catheters to reduce the risk of urinary tract infections in catheterized patients.
    Plowman R; Graves N; Esquivel J; Roberts JA
    J Hosp Infect; 2001 May; 48(1):33-42. PubMed ID: 11358469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Economic impact of healthcare-associated infections].
    Agozzino E; Di Palma MA; Gimigliano A; Piro A
    Ig Sanita Pubbl; 2008; 64(5):655-70. PubMed ID: 19188940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.